Kymera Therapeutics KYMR
NASDAQ KYMR
$134.84 -1.80 (-1.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Kymera Therapeutics (KYMR) Change in Accrued Expenses (2019 - 2026)

Updated

Kymera Therapeutics (KYMR) reported Change in Accrued Expenses of $13.49 million for Q2 2026, up 184.0% from $4.75 million a year earlier.

Analysis

Kymera Therapeutics (KYMR) Change in Accrued Expenses (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kymera Therapeutics' Change in Accrued Expenses came in at $20.61 million, up 326.5% year-over-year; for FY2025, it was $7.39 million, up 76.7% from FY2024.

  • Change in Accrued Expenses has a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
  • By year, Change in Accrued Expenses came in at $4.18 million in FY2024 (+31.4%), $3.18 million in FY2023 (-29.6%), $4.52 million in FY2022 (-64.1%) and $12.6 million in FY2021 (+119.0%).
  • Five-year quarterly Change in Accrued Expenses spans a low of -$15.39 million in Q1 2024 and a high of $13.66 million in Q4 2025.
  • Year over year, Change in Accrued Expenses gained in four of the last six quarters, with growth averaging 26.2%.
  • The high point for year-over-year Change in Accrued Expenses in five years was Q2 2023 (growth of 578.3%); the low point was Q2 2022 (a decline of 85.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$7.21 million (Q1 2026), $13.66 million (Q4 2025) and $664,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Kymera Therapeutics 11.66 Bn 8.50 Bn - 14.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.84 Mn
Jun 30, 2026 13.49 Mn
Mar 31, 2026 -7.21 Mn
Dec 31, 2025 13.66 Mn
Sep 30, 2025 664,000.00
Jun 30, 2025 4.75 Mn
Mar 31, 2025 -11.69 Mn
Dec 31, 2024 9.02 Mn
Sep 30, 2024 2.75 Mn
Jun 30, 2024 7.80 Mn
Mar 31, 2024 -15.39 Mn
Dec 31, 2023 6.79 Mn
Sep 30, 2023 2.64 Mn
Jun 30, 2023 3.79 Mn
Mar 31, 2023 -10.04 Mn
Dec 31, 2022 2.84 Mn
Sep 30, 2022 3.40 Mn
Jun 30, 2022 558,000.00
Mar 31, 2022 -2.28 Mn
Dec 31, 2021 3.80 Mn
API Access

Kymera Therapeutics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=KYMR&period=max&api_key=YOUR_API_KEY